COVID-19 update: June 23, 2022
FDA authorizes Moderna and Pfizer-BioNTech vaccines for children from 6 months of age
FDA authorizes Moderna and Pfizer-BioNTech vaccines for children from 6 months of age
CDC guidance for determining recommended number of COVID-19 vaccine doses and NIH updates vaccine guidance for potential organ donors
FDA expands Pfizer-BioNTech vaccine booster eligibility to children 5 through 11 years and authorizes first nonprescription COVID-19 test that also detects flu and RSV
FDA limits Janssen COVID-19 vaccine and announces tentative vaccines discussion. NIH updates Evusheld second dose guidance.
COVID-19 Summary of Evidence report updated, FDA approves first COVID-19 treatment for young children and authorizes breath samples diagnostic test
Sotrovimab distribution paused nationwide, how to locate Evusheld therapy and answers to your patients important questions